Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Illumina, Inc.    ILMN   US4523271090

ILLUMINA, INC. (ILMN)

58
Delayed Quote. Delayed Nasdaq - 11/21 04:00:00 pm
185.83 USD   -0.23%
3d ago ILLUMINA : U.S. Agency Forges Partnership to Curb Ebola
4d ago ILLUMINA : USAID, Broad Institute and Illumina Form a Public-Private Partne..
5d ago NASDAQ 100 MOVERS : Spls, ilmn
 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/17/2014 11/18/2014 11/19/2014 11/20/2014 11/21/2014 Date
182.91(c) 189.85(c) 190.03(c) 186.26(c) 185.83(c) Last
1 301 341 1 181 058 661 752 900 748 796 089 Volume
+1.34% +3.79% +0.09% -1.98% -0.23% Change
More quotes
Company
Illumina, Inc. develops, manufactures and markets life science tools and integrated systems for the analysis of genetic variation and function.The company provides sequencing and array-based solutions for genotyping, copy-number variation analysis, methylation studies and gene expression profiling... 
Surperformance© rating of Illumina, Inc.
Trading Rating : Investor Rating :
More about the company
Chart ILLUMINA, INC.
Duration : Period :
Illumina, Inc. Technical Analysis Chart | ILMN | US4523271090 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 1 855 M
EBIT 2014 532 M
Net income 2014 296 M
Debt 2014 602 M
Yield 2014 -
Sales 2015 2 266 M
EBIT 2015 662 M
Net income 2015 391 M
Finance 2015 496 M
Yield 2015 -
PER 2014 93,19
PER 2015 69,70
EV / Sales 2014 14,6x
EV / Sales 2015 11,5x
Capitalization 26 449 M
More Financials
Latest news on ILLUMINA, INC.
1d ago ILLUMINA : bioMerieux and Illumina Reach Agreement
3d ago ILLUMINA : Modification to a Previous Presolicitation Notice - 66-- Notice of In..
3d ago ILLUMINA : USAID, Broad Institute and Illumina Form a Public-Private Partnership..
3d ago ILLUMINA : U.S. Agency Forges Partnership to Curb Ebola
4d ago ILLUMINA : Researchers Submit Patent Application, "Patterned Flow-Cells Useful f..
4d ago ILLUMINA : Patent Issued for Formylpyrrole-Based Heterocycles for Nucleic Acid A..
4d ago ILLUMINA : Patent Issued for Confocal Imaging Methods and Apparatus
4d ago ILLUMINA : USAID, Broad Institute and Illumina Form a Public-Private Partnership..
5d ago NASDAQ 100 MOVERS : Spls, ilmn
5d ago ILLUMINA : bioMérieux and Illumina Enter Agreement to Co-Develop a Next-Generati..
6d ago ILLUMINA : Presolicitation Notice - COMPREHENSIVE CONTRACT RENEWAL FOR AN ILLUMI..
6d ago ILLUMINA : Assigned Patent
More news
4-Traders Strategies on ILLUMINA, INC. 
2013End of the technical recovery
More Strategies


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF